Atrás
Precio Alps Group Inc (GLLIR)
Gráfico del Precio de Acciones GLLIR
GLLIR Ganando
Alps Group Inc
$0.26
13.04%
$0.03
Hasta hoy:Jan 26, 15:07:34 GMT-5
Earnings FAQ
¿Cómo se comparó el EPS reciente de GLLIR con las expectativas?
¿Cómo fue el desempeño de los ingresos de Alps Group Inc GLLIR en el último trimestre?
¿Cuál es la estimación de ingresos para Alps Group Inc?
¿Cuál es la puntuación de calidad de ganancias de Alps Group Inc?
¿Cuándo informa Alps Group Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Alps Group Inc?
¿Superó Alps Group Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0.23
Precio de apertura
$0.221
Rango del día
$0.22 - $0.28
Rango de 52 semanas
$0.22 - $0.28
Volumen
120.4K
Volumen promedio
438.3K
EPS (TTM)
-0.51
Rendimiento de dividendos
--
Cap. de mercado
$43.2M
¿Qué es GLLIR?
Alps Group Inc is a MY-based company operating in Biotechnology industry. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved